Literature DB >> 1648507

Activity of soluble factors produced by Epstein-Barr virus-transformed human B lymphocytes on different cell lines.

C Garzelli1, A Bazzichi.   

Abstract

Self-stimulatory growth factors, produced by a human Epstein-Barr virus (EBV)-positive lymphoblastoid B cell line, named BA-D10-4, have been tested for the capacity to induce DNA synthesis in various human and animal cell lines, including lymphoid, either EBV-positive or EBV-negative, and non-lymphoid cell lines. It has been found that BA-D10-4 cells produce growth factors which seem to be essential for their sustained proliferation in vitro, and which increase DNA synthesis in different primate lymphoid cells, independently of the presence of the EBV genome and of the lymphocyte lineage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648507     DOI: 10.1007/bf01958829

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  25 in total

1.  Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.

Authors:  T Yokoi; T Miyawaki; A Yachie; K Kato; Y Kasahara; N Taniguchi
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

Review 2.  Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

Authors:  G Klein
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

3.  Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

4.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.

Authors:  H Wakasugi; L Rimsky; Y Mahe; A M Kamel; D Fradelizi; T Tursz; J Bertoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

7.  Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.

Authors:  J E Shaw; L A Baglia; K Leung
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

9.  Inhibitors of DNA synthesis produced by herpesvirus-transformed cell lines.

Authors:  J Beneke; G R Pearson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

10.  Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.

Authors:  G Scala; G Morrone; M Tamburrini; F Alfinito; C I Pastore; G D'Alessio; S Venuta
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.